Major Depressive Disorder: Next-Generation Neurosteroids

Earn CME for related activities: www.naccme.com/cme
This webcast features presentations that examine the diverse pathophysiologic mechanisms that may contribute to MDD and PPD and the resultant implications for therapeutic targeting, including the GABAergic signaling pathway.
© 2019 NACCME, an HMP Company

[@pauljones9150]

Wow very interesting. More neurosteroids talks please

[@anthoniosmith]

This is gold! tanks so much. Please more great content like this!

[@fineartlifestyling]

Excellent presentation. Learning about allopregnanolone and how it can assist with PMDD in future.

[@beckyweaver5981]

Why no comments?

[@MetatroN197924]

5a reductase enzyme could be the reason for depression?

[@user-te1ot7ux7c]

Blocking 5aR2 would reduce allopregnanolone

[@BrainPowerSubs]

lack of thereof, low 5AR1 activity will lead to low allopregnanolone thus making one more prone to depression